Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

TAKTAK
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in TAKEDA PHARMACEUTICAL CO LTD

GOLDMAN SACHS GROUP INC holds 5.1M shares of TAK (TAKEDA PHARMACEUTICAL CO LTD), worth $82.2M as of 2026-Q2. The position was decreased (-8.8% shares). TAK represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$82.2M

Current Shares

5.1M

Total Value Change

+$20.9M

Total Shares Change

+496,643

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
5.1M
-8.8%
$82.2M0.0%$16.03
0
2026-Q1
Increased
5.6M
+16.9%
$104.1M0.0%$18.08
35
2025-Q4
Decreased
4.8M
-3.0%
$74.9M0.0%$15.63
0
2025-Q3
Increased
5M
+10.1%
$72.5M0.0%$14.62
33
2025-Q2
Decreased
4.5M
-15.4%
$69.6M0.0%$15.10
0
2025-Q1
Increased
5.3M
+15.0%
$79.1M0.0%$14.71
34
2024-Q4
New
4.6M
-
$61.3M0.0%$12.87
41

Other major holders of TAK: BNP PARIBAS FINANCIAL MARKETS, GLENVIEW CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used